Mechanisms regulating the intracellular trafficking and release of CLN5 and CTSD
Robert J. Huber,William D. Kim,Morgan L. D. M. Wilson‐Smillie
DOI: https://doi.org/10.1111/tra.12925
2024-01-23
Traffic
Abstract:Working model showing the pathways and cellular components regulating the release of ceroid lipofuscinosis neuronal 5 (Cln5) and cathepsin D (CtsD) from cells. Cln5 and CtsD are synthesized and glycosylated (N) in the endoplasmic reticulum. Both proteins contain a functional signal peptide for secretion (SP) that facilitates their release from cells. Autophagy genes (atg1, atg5, atg9), autophagosomal‐lysosomal fusion, osmotic stress, and extracellular CtsD regulate the release of glycosylated Cln5. Cln5 also localizes to the cell periphery and contractile vacuole (CV) system. Like Cln5, autophagy genes and osmotic stress regulate the release of glycosylated CtsD. Cln5 and CtsD also localize to lysosomes and are released from cells via lysosomal exocytosis and a mechanism involving Apm3, LvsB, WshA, and microfilaments. Cln3, Mfsd8, and Mcln also play a role in regulating the release of Cln5 and CtsD. ABC transporters, microtubules, and the putative homologs of human sortilin (Sort1) and cation‐independent mannose‐6‐phosphate receptor (Mpr) regulate the intracellular/extracellular distribution of Cln5 and CtsD but are not required for their release from cells. Solid single arrows denote the direction of movement or involvement in the process depicted. Solid lines with one blunt end indicate an inhibitory effect on the process depicted. Dashed double arrows indicate an experimentally verified interaction between two proteins. Figure generated using BioRender. Ceroid lipofuscinosis neuronal 5 (CLN5) and cathepsin D (CTSD) are soluble lysosomal enzymes that also localize extracellularly. In humans, homozygous mutations in CLN5 and CTSD cause CLN5 disease and CLN10 disease, respectively, which are two subtypes of neuronal ceroid lipofuscinosis (commonly known as Batten disease). The mechanisms regulating the intracellular trafficking of CLN5 and CTSD and their release from cells are not well understood. Here, we used the social amoeba Dictyostelium discoideum as a model system to examine the pathways and cellular components that regulate the intracellular trafficking and release of the D. discoideum homologs of human CLN5 (Cln5) and CTSD (CtsD). We show that both Cln5 and CtsD contain signal peptides for secretion that facilitate their release from cells. Like Cln5, extracellular CtsD is glycosylated. In addition, Cln5 release is regulated by the amount of extracellular CtsD. Autophagy induction promotes the release of Cln5, and to a lesser extent CtsD. Release of Cln5 requires the autophagy proteins Atg1, Atg5, and Atg9, as well as autophagosomal‐lysosomal fusion. Atg1 and Atg5 are required for the release of CtsD. Together, these data support a model where Cln5 and CtsD are actively released from cells via their signal peptides for secretion and pathways linked to autophagy. The release of Cln5 and CtsD from cells also requires microfilaments and the D. discoideum homologs of human AP‐3 complex mu subunit, the lysosomal‐trafficking regulator LYST, mucopilin‐1, and the Wiskott–Aldrich syndrome‐associated protein WASH, which all regulate lysosomal exocytosis in this model organism. These findings suggest that lysosomal exocytosis also facilitates the release of Cln5 and CtsD from cells. In addition, we report the roles of ABC transporters, microtubules, osmotic stress, and the putative D. discoideum homologs of human sortilin and cation‐independent mannose‐6‐phosphate receptor in regulating the intracellular/extracellular distribution of Cln5 and CtsD. In total, this study identifies the cellular mechanisms regulating the release of Cln5 and CtsD from D. discoideum cells and provides insight into how altered trafficking of CLN5 and CTSD causes disease in humans.
cell biology